Amphastar P (AMPH) support and resistance · P/E 12, rev $732.0M
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps Amphastar P (AMPH) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AMPH 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AMPH quote page for the session range and the stock page for the full model.
Not investment advice.